Bharat Biotech’s Covaxin shows encouraging results in clinical trials: Research paper

In a double-blind, randomised, multi-centre phase 2 clinical trials, a total of 380 healthy children and adults were randomised and administered two vaccine formulations in as many doses (four weeks apart).